288 related articles for article (PubMed ID: 9371697)
21. Telokin expression and the effect of hypoxia on its phosphorylation status in smooth muscle cells from small and large pulmonary arteries.
Madden JA; Dantuma MW; Sorokina EA; Weihrauch D; Kleinman JG
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1166-73. PubMed ID: 18375742
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1.
Morrison DL; Sanghera JS; Stewart J; Sutherland C; Walsh MP; Pelech SL
Biochem Cell Biol; 1996; 74(4):549-57. PubMed ID: 8960361
[TBL] [Abstract][Full Text] [Related]
23. Site-specific phosphorylation and point mutations of telokin modulate its Ca2+-desensitizing effect in smooth muscle.
Walker LA; MacDonald JA; Liu X; Nakamoto RK; Haystead TA; Somlyo AV; Somlyo AP
J Biol Chem; 2001 Jul; 276(27):24519-24. PubMed ID: 11346659
[TBL] [Abstract][Full Text] [Related]
24. Ca(2+)-calmodulin-dependent modification of smooth-muscle myosin light-chain kinase leading to its co-operative activation by calmodulin.
Sobieszek A; Strobl A; Ortner B; Babiychuk EB
Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):405-11. PubMed ID: 8240237
[TBL] [Abstract][Full Text] [Related]
25. Translocation of telokin by cGMP signaling in smooth muscle cells.
Komatsu S; Miyazaki K; Tuft RA; Ikebe M
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C752-61. PubMed ID: 12176732
[TBL] [Abstract][Full Text] [Related]
26. [Effect of preincubation on smooth muscle myosin light chain kinase activity].
Filenko AM; Sobieszek A
Ukr Biokhim Zh (1978); 1998; 70(3):39-43. PubMed ID: 9848178
[TBL] [Abstract][Full Text] [Related]
27. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
Foster CJ; Johnston SA; Sunday B; Gaeta FC
Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
[TBL] [Abstract][Full Text] [Related]
28. Characterization of tightly associated smooth muscle myosin-myosin light-chain kinase-calmodulin complexes.
Hong F; Haldeman BD; John OA; Brewer PD; Wu YY; Ni S; Wilson DP; Walsh MP; Baker JE; Cremo CR
J Mol Biol; 2009 Jul; 390(5):879-92. PubMed ID: 19477187
[TBL] [Abstract][Full Text] [Related]
29. Novel phosphospecific antibodies for monitoring phosphorylation of proteins encoded by the myosin light chain kinase genetic locus.
Khapchaev AY; Krymsky MA; Sidorova MV; Bespalova ZhD; Wang CL; Shirinsky VP; Vorotnikov AV
Biochemistry (Mosc); 2004 Jul; 69(7):789-98. PubMed ID: 15310280
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the cross-bridge cycle: the effects of MgADP, LC17 isoforms and telokin.
Somlyo AV; Matthew JD; Wu X; Khromov AS; Somlyo AP
Acta Physiol Scand; 1998 Dec; 164(4):381-8. PubMed ID: 9887962
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of zipper-interacting protein kinase function in smooth muscle by a myosin light chain kinase pseudosubstrate peptide.
Ihara E; Edwards E; Borman MA; Wilson DP; Walsh MP; MacDonald JA
Am J Physiol Cell Physiol; 2007 May; 292(5):C1951-9. PubMed ID: 17215325
[TBL] [Abstract][Full Text] [Related]
32. Signaling through myosin light chain kinase in smooth muscles.
Gao N; Huang J; He W; Zhu M; Kamm KE; Stull JT
J Biol Chem; 2013 Mar; 288(11):7596-7605. PubMed ID: 23362260
[TBL] [Abstract][Full Text] [Related]
33. Effects of modulators of myosin light-chain kinase activity in single smooth muscle cells.
Itoh T; Ikebe M; Kargacin GJ; Hartshorne DJ; Kemp BE; Fay FS
Nature; 1989 Mar; 338(6211):164-7. PubMed ID: 2493140
[TBL] [Abstract][Full Text] [Related]
34. Enzyme kinetic characterization of the smooth muscle myosin phosphorylating system: activation by calcium and calmodulin and possible inhibitory mechanisms of antagonists.
Sobieszek A
Biochim Biophys Acta; 1999 May; 1450(1):77-91. PubMed ID: 10231558
[TBL] [Abstract][Full Text] [Related]
35. [Functional properties and intracellular localization of high molecular weight isoforms of ligh chain myosin kinase].
Chibalina MV; Kudriashov DS; Shekhonin BV; Shirinskiĭ VP
Tsitologiia; 2000; 42(3):248-55. PubMed ID: 10808549
[TBL] [Abstract][Full Text] [Related]
36. Site-specific dephosphorylation of smooth muscle myosin light chain kinase by protein phosphatases 1 and 2A.
Nomura M; Stull JT; Kamm KE; Mumby MC
Biochemistry; 1992 Dec; 31(47):11915-20. PubMed ID: 1332778
[TBL] [Abstract][Full Text] [Related]
37. Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse.
Isotani E; Zhi G; Lau KS; Huang J; Mizuno Y; Persechini A; Geguchadze R; Kamm KE; Stull JT
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6279-84. PubMed ID: 15071183
[TBL] [Abstract][Full Text] [Related]
38. Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation.
Khromov AS; Wang H; Choudhury N; McDuffie M; Herring BP; Nakamoto R; Owens GK; Somlyo AP; Somlyo AV
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2440-5. PubMed ID: 16461919
[TBL] [Abstract][Full Text] [Related]
39. The smooth muscle 132 kDa cyclic GMP-dependent protein kinase substrate is not myosin light chain kinase or caldesmon.
Sarcevic B; Robinson PJ; Pearson RB; Kemp BE
Biochem J; 1990 Oct; 271(2):493-9. PubMed ID: 2173564
[TBL] [Abstract][Full Text] [Related]
40. Regulation of myosin light chain kinase: kinetic mechanism, autophosphorylation, and cooperative activation by Ca2+ and calmodulin.
Sobieszek A
Can J Physiol Pharmacol; 1994 Nov; 72(11):1368-76. PubMed ID: 7767880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
